(Central News Agency reporter Su Siyun, Taipei, 25th) The 69th meeting of the Science Park Review Committee of the Ministry of Science and Technology passed 11 investment cases today, with a total investment amount of NT$2.781 billion. Yidatong, a company in the integrated circuit industry, has invested 1 billion yuan in Zhuke and is expected to seize business opportunities in third-generation semiconductor applications.

iNIFINITYrf Technology will invest 1 billion yuan in Zhuke Hsinchu Park. Its main products are gallium nitride wafers, digital mobile communications and wireless local network power amplifier components and system modules, microwave semiconductor component wafers, power amplifier components and system modules. Group.

The Ministry of Science and Technology stated that gallium nitride power components are currently widely used in 5G communication systems, automotive electronics, national defense and satellite communications and other markets, and are a must-have for military strategists in the third-generation semiconductor application field. EdaTong is a new start-up company established as a spin-off from the Ministry of Science and Technology's Price Innovation Plan. It develops technical capabilities for vertical integration of gallium nitride wafers and components from epitaxy, component manufacturing, simulation design, packaging and testing to chip modules. In the future, it is expected to combine the upstream and downstream semiconductor supply chains to seize the huge market for third-generation semiconductor applications.

Another index case is Taibao Biomedical, which belongs to the biotechnology industry. It also invested 1 billion yuan in Zhuke Hsinchu Biomedical Park. The main products are allogeneic stem cell new drug development and cell therapy and commissioned R&D and manufacturing services (CDMO).

The Ministry of Science and Technology stated that Taibao Biomedical has complete technologies such as mesenchymal stem cell isolation, expansion and cryopreservation, and has 12 cell preparation centers. It has developed new bone marrow-derived allogeneic stem cell drugs, which are mainly used to treat degenerative arthritis of the knee. Expand cell culture technology into the field of cell therapy. In the future, it is expected to provide high-quality cell therapy services to medical institutions and patients.

The Ministry of Science and Technology pointed out that among the 11 cases passed today, the rest include the precision machinery industry and the Park Branch of Next Year Energy Co., Ltd.; the biotechnology industry's Haoyuexing Biomedical and Ruiti Medical Co., Ltd. Equipment Zhongke Branch , Taiwan Advantage Sensing, Pair Biotech Pharmaceuticals, Nanke Branch of Vichosen Medical Co., Ltd.; Nanke Branch of Diwei Intelligent Co., Ltd. in the computer peripheral industry; industrial connectivity in the integrated circuit industry; and industrial park undertakings Jin Zhaoga and others.

In addition, there are 1 cases of Zhongguang Electronics Intelligent Robot Co., Ltd. establishing a Nanke branch, 4 cases of increasing products and business projects, and 6 cases of capital increase, with a total capital increase of 995 million yuan.